22Nov 2018

RESISTANCE PROFILE OF ENTEROBACTERIACEAE ACQUIREDIN URINARY TRACT INFECTIONS IN A REGIONAL HOSPITAL IN TANGIERSNORTHERN MOROCCO.

  • Equipe de Recherche en Biotechnologie et Genie des Biomolecules (ERBGB) ? Faculte des sciences et technique de Tanger .
  • Laboratoire de la Microbiologie, hopital Mohamed V de Tanger .
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Urinary tract infections are the most recorded infections in the microbiology laboratory. The enterobacteria are the most commonly isolated bacteria in these types of infections. The present work aims to study the frequency of isolated strains of Enterobacteriaceaecytobacteriological urinalysis from the microbiology laboratory of Mohamed V Tangier hospital and determine their resistance patterns to antibiotics. This is a retrospective study, which took place over a period of 24 months (January 2013 to December 2014) on 2716 urine samples, 410 examinations met the criteria for urinary tract infection including 325 (11.9%) Enterobacteriaceae strains were isolated. The identification was done by API 20 E galleries, sex ratio female / male was 1.69, Isolated bacterial species are dominated by Escherichia coli with 259 (83%), at its enterobacterial strains resistance to amoxicillin was 88.6%, and 68.3% in the protected amoxicillin, resistance to trimethoprim + sulfam?thoxazoles was equal to 33.2%, resistance to fluoroquinolones (ciprofloxacin) was 20.3%, aminoglycosides (Gentamycin) is 14.15%, fosfomycin was 11.7%, while the sensitivity to 3rd generation cephalosporins (ceftazidime) was 7.7%. 14 cases of resistance to beta lactamase extended spectrum (ESBL) was recorded which represents 4.3%, while for cases (1.2%) of resistance to carbapenems were recorded among these isolated Enterobacteriaceae strains. This study appears to reinforce other studies that shed light on antibiotic resistance, which is an issue of growing concern which leads us to recommend a more focused use of antibiotics.

  1. Chaurasia, Deepti, Rakesh Kumar Shrivastava, S. K. Shrivastava, Deepak Dubey, and M. C. Songra. ?Bacterial pathogens and their antimicrobial susceptibility pattern isolated from urinary tract infection in a tertiary care centre,? 2015. http://advancejournals.org/uploads/6185cfaffb13e15d4af417a79cd42cc9f5fdccbd9818017bfb063c2ff3dc5d41/Manuscript/3094674IJPBS%2010.pdf.
  2. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol2010;7:653-60 (2010); doi:10.1038/nrurol.2010.190
  3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplements. CLSI document M100-S24. Wayne, PA: CLSI, 2014.
  4. Antonio Sorlozano, Antonio Jimenez-Pacheco, Juan de Dios, Luna Del Castillo, Antonio Sampedro, Antonio Martinez-Brocal, Consuelo Miranda-Casas, Jos? Maria Navarro-Mari, Jos? Guti?rrez-Fernandez, Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: 1 7-year surveillance study, 2014 American journal of infection control 42 (2014) 1033-8
  5. Agence fran?aise de s?curit? sanitaire des produits de sant?. Diagnostic et antibioth?rapie des infections urinaires bact?riennes communautaires chez l?adulte ; 2008. http://www.afssaps.sante.fr.
  6. Agence fran?aise de s?curit? sanitaire des produits de sant?. Diagnostic et antibioth?rapie des infections urinaires bact?riennes communautaires du nourrisson et de l?enfant ; 2007. http://www.afssaps.sante.fr.
  7. Stamm WE. Measurement of pyuria and its relation to bacteriuria. Am J Med 1983; 75(1B):53?8.
  8. Tambyah PA, Maki DG. The relationship between pyuria and infection in patients with indwelling urinary catheters. Arch Int med 2000; 160:673?7.
  9. Bergogne-B?r?zin, Antibioth?rapie des infections urinaires basses : bases cliniques, microbiologiques et pharmacologiques Antibiotiques 2006 ; 8 : 51-62
  10. Quentin C, Arpin C, and Dubois V. Antibiotic Resistance Rates and Phenotypes Among Isolates of Enterobacteriaceae in French Extra-Hospital Practice. Eur J ClinMicrobiol Infect Dis 2004; 23: 185-93.
  11. El Bouamri, M.C., L. Arsalane, Y. Kamouni, M. Berraha, and S. Zouhair. ??volution r?cente du profil ?pid?miologique des ent?robact?ries uropathog?nes productrices de β-lactamases ? spectre ?largi ? Marrakech, Maroc.? Progr?senUrologie 24, no. 7 (June 2014): 451?55. doi:10.1016/j.purol.2013.11.010.
  12. Lahlou Amine, I., M. Chegri, and H. L?Kassmi. ??pid?miologie et r?sistance aux antibiotiques des ent?robact?ries isol?es d?infections urinaires ? l?h?pital militaire Moulay-Ismail de Mekn?s.? Antibiotiques 11, no. 2 (May 2009): 90?96. doi:10.1016/j.antib.2008.10.004.
  13. Warren, J. W. et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).Clin. Infect. Dis. 29, 745?758 (1999).
  14. Rubin, R. H., Shapiro, E. D., Andriole, v. T., Davis, r. J. &Stamm, W. E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. 15 (Suppl. 1), S216?S227(1992).
  15. Hooton, T. M. et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis. 50, 625?663 (2010)
  16. Stamm, W. E. Scientific and clinical challenges in the management of urinary tract infections. Am. J. Med. 113 (Suppl. 1A), 1S?4S (2002).
  17. Schito, G. C. et al. The ArESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int. J. Antimicrob. Agents 34, 407?413 (2009).
  18. Zhanel, G. G. et al. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 26, 380?388 (2005).
  19. Tlamcani Z, Ellaia K, Benomar A, Kabbaj H, Alaoui AE, SeffarM.La r?sistance aux fluoroquinolones chez des souches de Klebsiellaspp.productrices de betalactamase ? spectre?tenduisol?esdans les urines.AnnBiolClin 2009;67:553?6.
  20. Barguigua A, El Otmani F, Talmi M, Bourjilat F, Haouzane F, Zer-ouali K, et al. ?Characterization of ESBL-producing Escherichia coliandKlebsiellapneumoniae isolates from community in Morocco?. JMedMicrobiol 2011;60:1344?52.
  21. Cavallo, J.-D, and ? Garrab?. ?Outils du diagnostic biologique des infections urinaires nosocomiales (IUN) : analyse critique.? M?decineet Maladies Infectieuses 33, no. 9 (September 2003): 447?56. doi:10.1016/S0399-077X(03)00161-6.
  22. Ferjani, A., M. Marzouk, F. Ben Moussa, and J. Boukadida. ?R?sistance des souches d?Escherichia coli isol?es de pr?l?vements d?origine urinaire vis-?-vis de l?association amoxicilline?acide clavulanique et divers antibiotiques.? M?decineet Maladies Infectieuses 40, no. 3 (March 2010): 161?64. doi:10.1016/j.medmal.2009.06.007.
  23. Zowawi, H.M., Harris, P.N.A., Roberts, M.J., Tambyah, P.A., Schembri, M.A., Pezzani, M.D., Williamson, D.A., Paterson, D.L., 2015. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nature Reviews Urology 12, 570?584. doi:10.1038/nrurol.2015.199

[Younes mahrach, abdelhay arakrak mohammed bakkali and amin laglaoui. (2018); RESISTANCE PROFILE OF ENTEROBACTERIACEAE ACQUIREDIN URINARY TRACT INFECTIONS IN A REGIONAL HOSPITAL IN TANGIERSNORTHERN MOROCCO. Int. J. of Adv. Res. 6 (Nov). 1043-1048] (ISSN 2320-5407). www.journalijar.com

Younes MAHRACH
PHD student

DOI:

Article DOI: 10.21474/IJAR01/8091      
DOI URL: https://dx.doi.org/10.21474/IJAR01/8091

Download Full Paper

Download PDF No. of Downloads: 11 | No. of Views: 65